Other authors, such as Vavricka et al. (5) observed that AS was the third most responsive type of EIM to anti-TNF therapy (78.10%; n=25/32) and that the only predictor observed for a lower anti-TNF response was the presence of UC or IBD-U (OR=0.337; p=0.0139). This evidence concerns the gene TNF and inflammatory bowel disease.